We suspect that while LMP1-mediated inhibition of PERK and GCN2 kinase activity may promote the earliest stages of NPC tumors, it may be deleterious for tumor survival at later stages of tumor development, helping to explain why LMP1 expression is often eventually lost in NPC tumors. Here, PDLIM7 is linked to neoplasm.